FindTrial
Sign In

Incremental infusion of atrial natriuretic peptide suppresses leptin secretion in healthy men.

Incremental infusion of atrial natriuretic peptide suppresses leptin secretion in healthy men.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024559
Enrollment
17
Registered
2021-06-21
Start date
2004-12-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperleptinemia

Interventions

Group 1: Incremental ANP infusion Group 2: Placebo infusion (isotonic saline)

Sponsors

Deutsches Zentrum für Luft- und Raumfahrt (DLR)Institut für Luft- und Raumfahrtmedizin
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: BMI 20-25 kg/m2 No medication

Exclusion criteria

Exclusion criteria: BMI 25 kg/m2 Any medication

Design outcomes

Primary

MeasureTime frame
Change in serum Leptin concentration over 135 min, measured by ELISA—

Secondary

MeasureTime frame
Change in concentrations of RBP4, Resistin, Visfatin, ANP, free fatty acids, glucose and glycerol in Serum over 135 min—

Countries

Germany

Contacts

Public ContactAndreas Birkenfeld

Universitätsklinikum Tübingen, Innere Medizin 4

andreas.birkenfeld@med.uni-tuebingen.de070712982735

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 9, 2026